Toronto Dominion Bank Has $4.58 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Toronto Dominion Bank lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 68.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 62,779 shares of the company’s stock after acquiring an additional 25,474 shares during the period. Toronto Dominion Bank’s holdings in Henry Schein were worth $4,577,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in HSIC. Clarkston Capital Partners LLC lifted its stake in Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares during the last quarter. Nuance Investments LLC raised its holdings in shares of Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after buying an additional 414,748 shares in the last quarter. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein during the 2nd quarter worth $46,683,000. SG Americas Securities LLC boosted its stake in Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock valued at $33,449,000 after buying an additional 432,187 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in Henry Schein in the third quarter valued at about $515,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 0.6 %

Shares of NASDAQ:HSIC opened at $76.60 on Friday. The firm has a market cap of $9.55 billion, a P/E ratio of 31.52, a P/E/G ratio of 2.31 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The business has a fifty day simple moving average of $72.25 and a 200 day simple moving average of $70.06. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue was up .4% compared to the same quarter last year. During the same period last year, the company earned $1.32 earnings per share. Analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of research reports. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Finally, Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Seven equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $78.89.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.